Login / Signup

Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors.

Gabriel EtienneCarole FaberesFréderic BauduerDidier AdikoFrançois LifermannCorinne DagadaCaroline LenoirAnna SchmittEmilie KleinMarie-Pierre FortFontanet BijouBeatrice TurcqFanny RobbesynFrançoise DurrieuLaura VersméeSamia MadeneMarius MoldovanSandrine KatsahianAnais Charles-NelsonAxelle LascauxFrançois-Xavier MahonStéphanie Dulucq
Published in: Cancer medicine (2021)
One third of CP-CML patients treated with TKI frontline fulfilled the selection criteria suggested by European LeukemiaNet TFR recommendations. Meeting selection criteria and second-generation TKI frontline were associated with the highest MRFS.
Keyphrases
  • chronic myeloid leukemia
  • tyrosine kinase
  • advanced non small cell lung cancer
  • clinical practice
  • acute myeloid leukemia
  • bone marrow
  • disease activity
  • combination therapy
  • drug induced
  • replacement therapy